BlackRock Health Sciences Opportunities Portfolio

Scorecard
3 / 5 Stars
Lipper
2 3 5 1 2
Zacks Investment Research
3 (Hold)
Standard & Poor's
3 / 5 Stars
TheStreet.com
A+ (Buy)

U.S. News evaluated 34 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all BlackRock funds

See full Health rankings

See more fund rankings

Performance

The fund has returned 44.63 percent over the past year, 23.82 percent over the past three years, 24.50 percent over the past five years, and 13.55 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date 10.1%
1 Year 44.6%
3 Years (Annualized) 23.8%
5 Years (Annualized) 24.5%
10 Years (Annualized) 13.6%

See more SHISX performance

Summary

The investment seeks to provide long-term growth of capital. The fund invests at least 80% of total assets in equity securities, primarily common stock, of companies in health science and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It concentrates its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.

Fees

Fees are Low compared to funds in the same category.
BlackRock Health Sciences Opportunities Portfolio has an expense ratio of 1.23 percent.

See more SHISX fees

Risk

Risk is Below Average compared to funds in the same category according to Morningstar.

See more SHISX risk